School of Pharmacy, Graduate School of Health, University of Technology, Sydney, NSW 2007, Australia.
Pharmacol Res. 2013 Oct;76:77-83. doi: 10.1016/j.phrs.2013.07.009. Epub 2013 Aug 2.
Multidrug resistance (MDR) is a major impediment to the overall success of chemotherapy in clinical oncology. MDR has been primarily attributed by the ATP-dependent transmembrane proteins, P-glycoprotein (P-gp, ABCB1) and Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1). These proteins maintain sublethal concentrations of intracellular chemotherapeutics by virtue of their drug efflux capacity. In this study, we report the acquisition and dissemination of functional MRP1 via microparticle (MP) mediated intercellular transfer. After we showed the transfer and functionality of P-gp in drug sensitive recipient cells, we report the transfer and time-dependent functionality of MRP1 in drug sensitive leukaemia cells following exposure to MPs shed by MRP1-overexpressing MDR cells. We also demonstrate a remarkable capacity for MPs shed from cells with a P-gp dominant resistance profile to re-template a pre-existing MRP1 dominant profile in recipient cells. These findings have significance in understanding the molecular basis for tumour dominant phenotypes and introduce potential new strategies and targets for the acquisition of MDR and other deleterious traits.
多药耐药性(MDR)是临床肿瘤化疗总体成功的主要障碍。MDR 主要归因于 ATP 依赖性跨膜蛋白,P-糖蛋白(P-gp,ABCB1)和多药耐药相关蛋白 1(MRP1,ABCC1)。这些蛋白质通过其药物外排能力维持细胞内化疗药物的亚致死浓度。在这项研究中,我们报告了通过微粒(MP)介导的细胞间转移获得和传播功能性 MRP1。在我们展示了药物敏感受体细胞中 P-gp 的转移和功能后,我们报告了在暴露于 MRP1 过表达 MDR 细胞释放的 MPs 后,药物敏感白血病细胞中 MRP1 的转移和时间依赖性功能。我们还证明了具有 P-gp 主导耐药谱的细胞释放的 MPs 具有重新模板化受体细胞中预先存在的 MRP1 主导谱的显著能力。这些发现对于理解肿瘤主导表型的分子基础具有重要意义,并为获得 MDR 和其他有害特征引入了潜在的新策略和靶点。